Home/Filings/4/0001209191-20-001888
4//SEC Filing

Aldag Jorn 4

Accession 0001209191-20-001888

CIK 0001622229other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:45 PM ET

Size

5.8 KB

Accession

0001209191-20-001888

Insider Transaction Report

Form 4
Period: 2020-01-02
Aldag Jorn
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-01-02$0.45/sh+29,790$13,50129,790 total
    Exercise: $0.72Exp: 2030-01-02Common Stock (29,790 underlying)
Footnotes (2)
  • [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
  • [F2]This option is fully vested at time of grant.

Issuer

Unum Therapeutics Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001734412

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:45 PM ET
Size
5.8 KB